Castello G - Search Results

1

Immunological phenotype analysis of patients with Fanconi's anaemia and their family members.

Castello G, Gallo C, Napolitano M, Ascierto PA. Castello G, et al. Acta Haematol. 1998;100(1):39-43. doi: 10.1159/000040861. Acta Haematol. 1998. PMID: 9691145

2

Immunological and clinical effects of intramuscular rIFN alpha-2a and low dose subcutaneous rIL-2 in patients with advanced malignant melanoma.

Castello G, Comella P, Manzo T, Napolitano M, Parziale AP, Galati MG, Daponte A, Casaretti R, Celentano E, Comella G. Castello G, et al. Melanoma Res. 1993 Feb;3(1):43-9. doi: 10.1097/00008390-199304000-00007. Melanoma Res. 1993. PMID: 8471836

3

Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group.

Palmieri G, Strazzullo M, Ascierto PA, Satriano SM, Daponte A, Castello G. Palmieri G, et al. Among authors: castello g. J Clin Oncol. 1999 Jan;17(1):304-11. doi: 10.1200/JCO.1999.17.1.304. J Clin Oncol. 1999. PMID: 10458247

4

Urinary neopterin and immunological features in patients with Kaposi's sarcoma.

Santelli G, Melillo G, Marfella A, Napolitano M, D'Alessio V, Satriano RA, Beth-Giraldo E, Giraldo G, Perna M, Castello G. Santelli G, et al. Among authors: castello g. Eur J Cancer Clin Oncol. 1988 Sep;24(9):1391-6. doi: 10.1016/0277-5379(88)90327-6. Eur J Cancer Clin Oncol. 1988. PMID: 3263274

5

Epiluminescence microscopy as a useful approach in the early diagnosis of cutaneous malignant melanoma.

Ascierto PA, Satriano RA, Palmieri G, Parasole R, Bosco L, Castello G. Ascierto PA, et al. Among authors: castello g. Melanoma Res. 1998 Dec;8(6):529-37. doi: 10.1097/00008390-199812000-00008. Melanoma Res. 1998. PMID: 9918415

6

3-year treatment with recombinant interferon-alpha as adjuvant therapy of cutaneous malignant melanoma.

Ascierto PA, Palmieri G, Parasole R, Daponte A, Castello G. Ascierto PA, et al. Among authors: castello g. Int J Mol Med. 1999 Mar;3(3):303-6. doi: 10.3892/ijmm.3.3.303. Int J Mol Med. 1999. PMID: 10028056 Clinical Trial.

7

Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction.

Palmieri G, Ascierto PA, Perrone F, Satriano SM, Ottaiano A, Daponte A, Napolitano M, Caracò C, Mozzillo N, Melucci MT, Cossu A, Tanda F, Gallo C, Satriano RA, Castello G. Palmieri G, et al. Among authors: castello g. J Clin Oncol. 2003 Mar 1;21(5):767-73. doi: 10.1200/JCO.2003.01.128. J Clin Oncol. 2003. PMID: 12610172 Review.

8

Prognostic value of serum VEGF in melanoma patients: a pilot study.

Ascierto PA, Leonardi E, Ottaiano A, Napolitano M, Scala S, Castello G. Ascierto PA, et al. Among authors: castello g. Anticancer Res. 2004 Nov-Dec;24(6):4255-8. Anticancer Res. 2004. PMID: 15736481 Free article.

9

Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.

Scala S, Ottaiano A, Ascierto PA, Cavalli M, Simeone E, Giuliano P, Napolitano M, Franco R, Botti G, Castello G. Scala S, et al. Among authors: castello g. Clin Cancer Res. 2005 Mar 1;11(5):1835-41. doi: 10.1158/1078-0432.CCR-04-1887. Clin Cancer Res. 2005. PMID: 15756007

10

Human melanoma metastases express functional CXCR4.

Scala S, Giuliano P, Ascierto PA, Ieranò C, Franco R, Napolitano M, Ottaiano A, Lombardi ML, Luongo M, Simeone E, Castiglia D, Mauro F, De Michele I, Calemma R, Botti G, Caracò C, Nicoletti G, Satriano RA, Castello G. Scala S, et al. Among authors: castello g. Clin Cancer Res. 2006 Apr 15;12(8):2427-33. doi: 10.1158/1078-0432.CCR-05-1940. Clin Cancer Res. 2006. PMID: 16638848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters